Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
NLSN
Nielsen Holdings plc
NLSN
|
$347M |
| 2 |
AstraZeneca
AZN
|
$311M |
| 3 |
Medtronic
MDT
|
$262M |
| 4 |
Eli Lilly
LLY
|
$219M |
| 5 |
Sempra
SRE
|
$210M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$727M |
| 2 |
Merck
MRK
|
$217M |
| 3 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
$211M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$196M |
| 5 |
VRN
Veren
VRN
|
$194M |
Sector Composition
| 1 | Financials | 13.99% |
| 2 | Healthcare | 13.28% |
| 3 | Industrials | 11.21% |
| 4 | Technology | 10.19% |
| 5 | Consumer Staples | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gilead Sciences
GILD
$140B
| $524M | 0.95% | 5,341,394 -937,106 | -15% | -$92M |
|
27
Marsh & McLennan
MMC
$101B
| $519M | 0.94% | 9,929,894 | – | – |
|
|
28
AstraZeneca
AZN
$248B
| $517M | 0.94% | 16,244,980 +9,781,890 | +151% | +$311M |
|
29
Carnival Corp
CCL
$43.2B
| $508M | 0.92% | 10,230,600 +160,000 | +2% | +$7.95M |
|
30
JPMorgan Chase
JPM
$829B
| $507M | 0.92% | 8,316,800 | – | – |
|
31
DuPont de Nemours
DD
$32.2B
| $505M | 0.92% | 11,909,552 -2,046,900 | -15% | -$86.8M |
|
32
Amazon
AMZN
$2.44T
| $487M | 0.88% | 951,207 +28,047 | +3% | +$14.4M |
|
33
AbbVie
ABBV
$372B
| $477M | 0.87% | 8,766,196 -1,685,000 | -16% | -$91.7M |
|
34
PG&E
PCG
$33.6B
| $460M | 0.83% | 8,712,300 | – | – |
|
35
Mondelez International
MDLZ
$79.5B
| $445M | 0.81% | 10,616,340 +3,164 | +0% | +$132K |
|
36
Altria Group
MO
$113B
| $436M | 0.79% | 8,015,610 +1,197,400 | +18% | +$65.1M |
|
|
37
Medtronic
MDT
$119B
| $427M | 0.77% | 6,376,877 +3,921,260 | +160% | +$262M |
|
38
Kinder Morgan
KMI
$60B
| $427M | 0.77% | 15,414,600 +1,126,800 | +8% | +$31.2M |
|
39
Alphabet (Google) Class C
GOOG
$2.58T
| $423M | 0.77% | 682,694 +39,704 | +6% | +$24.6M |
|
40
Royal Caribbean
RCL
$98.7B
| $413M | 0.75% | 4,636,218 +1,886 | +0% | +$168K |
|
41
Moody's
MCO
$91.4B
| $413M | 0.75% | 4,205,283 +125,867 | +3% | +$12.4M |
|
42
Booking.com
BKNG
$181B
| $408M | 0.74% | 330,254 +7,912 | +2% | +$9.79M |
|
43
PNC Financial Services
PNC
$81.7B
| $403M | 0.73% | 4,515,200 -425,000 | -9% | -$37.9M |
|
44
Quest Diagnostics
DGX
$20.3B
| $401M | 0.73% | 6,530,100 -243,900 | -4% | -$15M |
|
45
Norwegian Cruise Line
NCLH
$11.2B
| $392M | 0.71% | 6,832,712 +407,217 | +6% | +$23.3M |
|
46
GE Aerospace
GE
$292B
| $387M | 0.7% | 15,346,148 +966,252 | +7% | +$24.4M |
|
47
Amgen
AMGN
$155B
| $371M | 0.67% | 2,680,048 | – | – |
|
48
Accenture
ACN
$162B
| $370M | 0.67% | 3,766,100 | – | – |
|
49
Comcast
CMCSA
$125B
| $363M | 0.66% | 6,381,500 | – | – |
|
|
50
Merck
MRK
$210B
| $350M | 0.64% | 7,095,509 -4,383,871 | -38% | -$217M |
|